"10.1371_journal.pone.0015230","plos one","2010-12-16T00:00:00Z","Leonardo M Saraiva; Gisele S Seixas da Silva; Antonio Galina; Wagner S da-Silva; William L Klein; Sérgio T Ferreira; Fernanda G De Felice","Programa de Bioquímica e Biofísica Celular, Instituto de Bioquímica Médica, Universidade Federal do Rio de Janeiro, Rio de Janeiro, Rio de Janeiro, Brazil; Department of Neurobiology and Physiology, Northwestern University, Evanston, Illinois, United States of America","Conceived and designed the experiments: LMS FGDF STF GSSdS AG. Performed the experiments: LMS FGDF GSSdS WSdS. Analyzed the data: LMS FGDF GSSdS. Contributed reagents/materials/analysis tools: STF FGDF WLK. Wrote the paper: LMS FGDF STF GSSdS.","WLK is co-founder of Acumen Pharmaceuticals, which has been licensed by Northwestern University to develop ADDL technology for Alzheimers therapeutics and diagnostics. This does not alter the authors adherence to all the PLoS ONE policies on sharing data and materials.","2010","12","Leonardo M Saraiva","LMS",7,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA
